Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature.
23/11/2023
/
Publications
This systematic review summarized results of the literature in the setting of patients treated with hypofractionated PT for benign lesions of the central...
New developments in PT: Motion Management, DynamicARC® and ConformalFLASH®
26/05/2021
/
Webinar
/
FLASH Therapy
ARC therapy
Motion Management
Watch our session from the virtual NAPT 2021 conference with Dr. Alonso Gutierrez and Swati Ghandi presenting topics related to ConformalFLASH®, DynamicARC® and...
Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
23/11/2023
/
Publications
This study reported outcomes of 31 recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) patients treated with combined proton therapy and...
Risk of temporal lobe necrosis between proton beam and volumetric modulated arc therapies in patients with different head and neck cancers.
23/11/2023
/
Publications
This study reviewed 483 patients with various types of head and neck cancer (HNC), and reported that the nasopharyngeal carcinoma (NPC) patients had a higher...
Prospective Feasibility and Phase 1/2 Trial of Preoperative Proton Beam Therapy With Concurrent Chemotherapy for Resectable Stage IIIA or Superior Sulcus Non-Small Cell Lung Cancer.
23/11/2023
/
Publications
Published in the Red Journal, this is a brief report detailing a novel prospective feasibility and phase1/2 dose-scalation study of PBT as part of trimodality...
Concurrent chemoradiotherapy using proton beams can reduce cardiopulmonary morbidity in esophageal cancer patients: a systematic review.
23/11/2023
/
Publications
To examine the superiority of PBT to photon-based RT in treating esophageal cancer patients, this systematic review included 23 original studies (1 randomized...
Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma.
23/11/2023
/
Publications
A review article by the group from National Cancer Center, Korea detailed the dosimetric and clinical benefits of PBT in the settings of early, intermediate and...
Clinical and Dosimetric Results of Proton or Photon Radiotherapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective Analysis.
23/11/2023
/
Publications
Published in the Red Journal, this study from Taiwan retrospectively analyzed the outcomes of 159 patients with >5 cm non-metastatic HCC who underwent...
Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis.
23/11/2023
/
Publications
This study from Japan was set to compare the survival outcomes of PBT with those of radiofrequency ablation (RFA) in patients with treatment-naïve solitary HCC...
Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial.
23/11/2023
/
Publications
Published in the Lancet Oncology, this randomized phase 2 study by the Mayo group was set to compare conventional fractionated (50 Gy in 25 fractions of 2 Gy)...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.